Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination With Carboplatin Versus Carboplatin With Placebo in Patients With Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Primary Peritoneal Cancer Following at Least Second Line Platinum Therapy
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
The primary efficacy end-point is progression-free survival (PFS). PFS is the time from randomization until disease progression or death
Daniel P Gold, PhD
Study Director
MEI Pharma, Inc.
United States: Food and Drug Administration
NV06-0039
NCT00382811
October 2006
April 2011
Name | Location |
---|---|
Baylor College of Medicine | Houston, Texas 77030 |
Cedars-Sinai Medical Center | Los Angeles, California 90048 |
Carolinas Medical Center | Charlotte, North Carolina 28232-2861 |
MetroHealth Medical Center | Cleveland, Ohio 44109 |
Piedmont Hospital | Atlanta, Georgia 30309 |
Miami Valley Hospital | Dayton, Ohio 45409 |
Gabrail Cancer Center | Canton, Ohio 44718 |
Hematology and Oncology Specialists, LLC | New Orleans, Louisiana 70115 |
Arizona Clinical Research Center, Inc. | Tucson, Arizona 85712 |
Jersey Shore Medical Center | Neptune, New Jersey 07754 |
Chattanooga GYN Oncology | Chattanooga, Tennessee 37403 |
Yale University School Of Medicine | New Haven, Connecticut 06520 |
Gynecologic Oncology Associates | Pembroke Pines, Florida 33028 |
Associates in Women's Health | Wichita, Kansas 67214 |
Gynecologic Oncology of West Michigan | Grand Rapids, Michigan 49546 |
Schwartz Gynecologic Oncology | Brightwaters, New York 11718 |
Chattanooga's Program in Women's Oncology | Chattanooga, Tennessee 37403 |
Northern Virginia Pelvic Surgery Associates | Annandale, Virginia 22003 |
Gynecology Oncology Associates | Greenbrae, California |
Wake Forest University Health Sciences | Winston-Salem, North Carolina 27157 |
Sarah Cannon Research Institute | Nashville, Tennessee 37203 |
Kaiser Permanente Los Angeles Medical Center | Los Angeles, California 90027 |
New York Downtown Hospital | New York, New York 10038 |
Medical College of Georgia Cancer Center | Augusta, Georgia 30912-3500 |
Glendale Adventist | Glendale, California 91206 |
Hematology Oncology, PC (Carl and Dorothy Bennett Cancer Center) | Stamford, Connecticut 06902 |
Greater Baltimore Medical Centre | Baltimore, Maryland 21204 |
Providence Hospital and Medical Centers | Southfield, Michigan 48075 |
The Center for Cancer & Hematological Disease | Cherry Hill, New Jersey 08003 |
The University of New Mexico Cancer Research and Treatment Center | Albuquerque, New Mexico 87131-0001 |
University of Rochester Gynecologic Oncology Associates | Rochester, New York 14620 |
Brody School of Medical at East Carolina University | Greenville, North Carolina 27834 |
OSU James Cancer Hospital & Solove Research Institute | Columbus, Ohio 43210 |
Hall and Martin MDS, P.C. | Knoxville, Tennessee 37920 |
Hope Cancer Clinic | Brownsville, Texas 78526 |
University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center | Dallas, Texas 75390 |
Virginia Mason Medical Center Department of Hematology/Oncology | Seattle, Washington 98101 |